Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Molecular Pharmacology|April 17, 2008
Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampinHani Zaher, Henriette E Meyer zu Schwabedissen, Rommel G Tirona, et al.European Heart Journal|March 1, 2012
Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet responseInna Y Gong, Natalie Crown, Colin M Suen, et al.Biopharmaceutics & Drug Disposition|March 15, 2024
Aging and brain free cholesterol concentration on amyloid-β peptide accumulation in guinea pigsK Sandy Pang, H Benson Peng, Betty P Li, et al.Pharmacogenetics and Genomics|April 15, 2008
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probeBradley L Urquhart, Joseph A Ware, Rommel G Tirona, et al.Clinical Pharmacology and Therapeutics|March 18, 2023
Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine-Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic LeukemiaUte I Schwarz, Morgan Woldanski-Travaglini, Valerie Swanston, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2013
Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout miceLazar A Bojic, Amy C Burke, Sanjiv S Chhoker, et al.Nature Medicine|January 7, 2003
The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4Rommel G Tirona, Wooin Lee, Brenda F Leake, et al.Clinical Pharmacology and Therapeutics|June 18, 2003
Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juiceDavid G Bailey, George K Dresser, John R BendClinical Pharmacology and Therapeutics|March 1, 2005
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptidesGeorge K Dresser, Richard B Kim, David G BaileyPlos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.Pageof 10